Dr. Singh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1425 Madison Avenue
L620
New York, NY 10029Phone+1 917-892-9340
Summary
- Dr. Prameet Singh is a psychiatrist in New York, NY and is affiliated with Mount Sinai Morningside, Mount Sinai West, The Mount Sinai Hospital, Mount Sinai Beth Israel, Mount Sinai Brooklyn, Mount Sinai Hospital of Queens, and New York Eye and Ear Infirmary of Mount Sinai. He received his medical degree from Maulana Azad Medical College and has been in practice 27 years. He specializes in addiction and is experienced in schizophrenia, addiction psychiatry, mood disorders, and borderline personality disorder. He has 5 publications and over 50 citings.
Education & Training
- Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Psychiatry, 1991 - 1996
- Maulana Azad Medical CollegeClass of 1990
Certifications & Licensure
- NY State Medical License 1998 - 2026
- DE State Medical License 1996 - 2003
- PA State Medical License 1996 - 2000
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Addiction Psychiatry
Awards, Honors, & Recognition
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2014-2017
Publications & Presentations
PubMed
- 2 citationsCommunity Psychiatry Tracks for Residents: A Review of Four ProgramsClaudia L. Reardon, Robert M. Factor, Carolyn J. Brenner, Prameet Singh, Joyce A. Spurgeon
Community Mental Health Journal. 2014-01-01 - 5 citationsImplications of co-occurring alcohol abuse for role impairment, health problems, treatment seeking, and early course of alcohol dependence.Ramin Mojtabai, Prameet Singh
The American Journal on Addictions. 2007-07-08 - 65 citationsA randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal.John J. Mariani, Richard N. Rosenthal, Susan Tross, Prameet Singh, Om P. Anand
The American Journal on Addictions. 2006-01-02
Press Mentions
- How a 'Madman' Hopes to Spark Conversations About Mental IllnessOctober 4th, 2017
- Sunday Dialogue: Medicine as a BusinessFebruary 8th, 2014
- After Tragedy, Med School Pledges More CompassionDecember 13th, 2019
- Join now to see all
Professional Memberships
- Fellow
- American College of PsychiatryMember
- American Academy of Addiction PsychiatryMember
- American Association of Chairs of Departments of PsychiatryMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: